We at Insider Financial have been pounding the table all year on Peregrine Pharmaceuticals Inc (NASDAQ:PPHM). We’ve been ... For continuing coverage on PPHM, sign up for our free newsletter today and get our next hot stock pick! …
According to the complaint the plaintiff alleges on behalf of all persons who purchased Peregrine Pharmaceuticals …
On Monday February 22, 2016 shares of Chimerix tumbled by 40% as the company announced that two phase 3 trials had to be stopped because of lack of efficacy. The phase 3 trial, known as the SUPPRESS trial, recruited a total of 452 …
TUSTIN, Calif., July 07, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that a previously approved 1-for-7 reverse split of its outstanding shares of common stock will take …
As investors, we’ve learned that any time there is positive news released with regard to a publicly traded company, we can expect to see gains in the value of the stock associated with that company. That’s exactly what we’re seeing from PPHM.
The stock has Return on Assets (ROA) of -35.4 percent. Peregrine Pharmaceuticals, Inc. (PPHM) earnings have risen with an annualized rate of 13.1% over the last 5 years. As with most ratios, be aware that this varies by industry. For more …
Peregrine Pharmaceuticals, Inc. (PPHM) will report its next earnings on Jul 20 AMC ... Inc. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.01/share. These analysts have …
The stock of $252 million market capped biotech firm Peregrine Pharmaceuticals (NASDAQ:PPHM) plummeted by a huge 4.17 percent during trading on 6 th February, on the back of news of the drug firm offering preferred stock in the form …